Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Exmceuticals Inc C.EXM

Healthcare
EXMceuticals Inc. is a bio-sciences company that is focused on the production of cannabinoid formulations. The Company operates through its geographic segments, which include Canada, Portugal, Uganda and Netherlands. The Company’s subsidiaries include EXMceuticals Inc., EXMceuticals Holdings B.V, EXMceuticals Portugal, LDA and EXMceuticals Portugal II, Unipessoal Lda.

Recent & Breaking News (CSE:EXM)

CSE Bulletin: Suspensions (MMI, CNFA, VPN, NM, EXM)

Newsfile November 4, 2021

EXMceuticals Inc. Announces Resignation of Board Members

GlobeNewswire June 30, 2021

EXMceuticals Inc is Pleased to Announce the Signing of the Definitive Business Combination Agreement with Global Cannabinoids and Launch of its up-to $6,000,000 CAD Private Placement

GlobeNewswire May 11, 2021

EXMceuticals (CSE:EXM) merges with Global Cannabinoids and launches equity financing

Trevor Abes  March 3, 2021

EXMceuticals Inc. Announces Transformational Merger with Global Cannabinoids and Launches Concurrent Equity Financing

GlobeNewswire March 3, 2021

IIROC Trading Halt - EXM

Canada NewsWire March 1, 2021

IIROC Trade Resumption - EXM

Canada NewsWire February 1, 2021

IIROC Trading Halt - EXM

Canada NewsWire January 8, 2021

EXMceuticals Provides Bi-Weekly Default Status Report

GlobeNewswire December 10, 2020

EXMceuticals Provides Bi-Weekly Default Status Report

GlobeNewswire November 26, 2020

EXMceuticals Provides Bi-Weekly Default Status Report

GlobeNewswire November 12, 2020

EXMceuticals Announces Application for Voluntary Management Cease Trade Order

GlobeNewswire October 23, 2020

EXMceuticals Inc. becomes member of the Portuguese Association of the Pharmaceutical Industry (APIFARMA).

GlobeNewswire September 29, 2020

EXMceuticals Inc. Announces Receipt of Landmark COVID-19 Research Grant and Acceleration of Portuguese Activities

GlobeNewswire September 8, 2020

EXMceuticals Inc. Announces Advancement of R&D Operations in Portugal and Efforts to Fight COVID-19 Pandemic

GlobeNewswire August 25, 2020

EXMceuticals Inc. Announces Shares for Debt Settlement

GlobeNewswire August 21, 2020

EXMceuticals Inc. Announces Loan Settlement and Share Issuance

GlobeNewswire July 28, 2020

EXMceuticals Inc. Announces Closing of Oversubscribed Private Placement and Strategic Debt to Equity Conversion Strengthening the Corporation's Balance Sheet

GlobeNewswire July 22, 2020

EXMceuticals Inc. Strengthens Positioning as a Gateway to the European Market through Supply Agreement for THC Distillate

GlobeNewswire June 11, 2020

EXMceuticals Inc. Receives 45-Day Extension to File Quarterly Financial Statements

GlobeNewswire May 29, 2020